A recurrent ERCC3 truncating mutation confers moderate risk for breast cancer.
Times cited: 14
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
Cancer Prevention Research.
Times cited: 59
BLM heterozygosity and the risk of colorectal cancer.
Times cited: 129